Buzzing Politics
  • News
  • Privacy Policy
  • Terms of Use
  • Disclaimer
Select Page
Intuitive Machines Stock Slides 8% Thursday: What’s Driving The Action?

Intuitive Machines Stock Slides 8% Thursday: What’s Driving The Action?

by Henry Khederian | Mar 5, 2026 | General

Intuitive Machines Inc (NASDAQ:LUNR) shares are trading lower Thursday, as investors reassess a sharp early-week rally fueled by a new national-security contract for the space-technology company. Here’s what investors need to know. Intuitive Machines shares are...

Big Tech CapEx Set To Surge As AI Arms Race Shifts From Silicon To Power, Says Gene Munster

by Kaustubh Bagalkote | Mar 5, 2026 | General

The artificial intelligence spending war is entering a new phase. And it’s no longer just about chips. Gene Munster, managing partner of Deepwater Asset Management, said Wednesday that next year’s Big Tech capital expenditure will come in “meaningfully higher than...

Bitcoin Surges 7%, But The March Rally May Just Be A Textbook Bull Trap

by Parshwa Turakhiya | Mar 5, 2026 | General

Bitcoin (CRYPTO: BTC) has surged 7% since the start of the month as macro analyst Benjamin Cowen warned this mirrors the “bull trap” pattern that preceded massive sell-offs in every prior midterm cycle. The Midterm Bear Market Playbook Bitcoin is trading roughly 15%...
Cracker Barrel Analysts Boost Their Forecasts After Upbeat Q2 Earnings

Cracker Barrel Analysts Boost Their Forecasts After Upbeat Q2 Earnings

by Avi Kapoor | Mar 5, 2026 | General

Cracker Barrel Old Country Store Inc. (NASDAQ:CBRL) reported upbeat fiscal second-quarter earnings on Wednesday. Total revenue of the American restaurant and gift store chain fell 7.9% year-over-year to $874.8 million, slightly missing the analyst estimate of $876.94...

FDA Defends Call For Placebo Study In uniQure Huntington’s Gene Therapy Trial

by Vandana Singh | Mar 5, 2026 | General

An official from the U.S. Food and Drug Administration (FDA) defended the agency’s request for a new placebo-controlled study for uniQure N.V.’s (NASDAQ:QURE) experimental gene therapy for Huntington’s disease. The FDA official noted that the...

EXCLUSIVE: Neobank Dave Taps AI Across the Stack To Smash Q4 Estimates

by Erica Kollmann | Mar 5, 2026 | General

Dave Inc. (NASDAQ:DAVE) reported a strong fourth-quarter, with its AI-driven underwriting platform CashAI v5.5 powering a 50% year-over-year increase in ExtraCash originations and improving the 28-day past due rate to just 1.89%.  DAVE stock is moving. See the chart...
« Older Entries
Next Entries »

Recent Posts

  • $1000 Invested In Amazon.com 20 Years Ago Would Be Worth This Much Today
  • Here’s How Much You Would Have Made Owning Amphenol Stock In The Last 15 Years
  • Here’s How Much You Would Have Made Owning Netflix Stock In The Last 15 Years
  • A Look Into Coeur Mining Inc’s Price Over Earnings
  • Groupon Stock Is 13% Off After Q4 Earnings Disappoint

Recent Comments

    Archives

    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019

    Categories

    • Breaking
    • Business
    • Daily
    • General
    • Markets
    • News
    • Reports
    • Technology

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • News
    • Privacy Policy
    • Terms of Use
    • Disclaimer
    Copyright 2019 Karmaholic Media LLC. All Rights Reserved.